Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
Chinese Patent Office
Daiichi Sankyo
Argus Health
QuintilesIMS
Merck
Accenture
McKinsey

Generated: July 21, 2018

DrugPatentWatch Database Preview

Hydroxyurea - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Pharmacology for hydroxyurea
Ingredient-typeUrea
Drug ClassAntimetabolite
Medical Subject Heading (MeSH) Categories for hydroxyurea
Synonyms for hydroxyurea
1-HYDROXYUREA
1-oxidanylurea
127-07-1
127H071
4-03-00-00170 (Beilstein Handbook Reference)
A805636
AB00052018_11
AB00052018_12
AB00052018-09
AB00052018-10
AB0013265
AB1009531
AC-22674
AC1L1GF8
AC1Q4ZXK
ACMC-1C22W
ACT02611
AI3-51139
AK128930
AKOS005716276
AKOS006222547
ALBB-028465
aminohydroxamic acid
AN-6974
ANW-18958
BB_SC-7256
BBL009928
BDBM50017811
Bio1_000451
Bio1_000940
Bio1_001429
Biosupressin
BRN 1741548
BSPBio_002164
C07044
carbamic acid oxime
carbamide oxide
Carbamohydroxamic acid
Carbamohydroximic acid
Carbamohydroxyamic acid
Carbamoyl oxime
Carbamyl hydroxamate
Carbomohydroxamic acid
Carrbamoyl Oxime
CAS-127-07-1
CCG-35236
CCRIS 958
CHEBI:44423
CHEMBL467
CS-2353
CTK3J0738
Cytodrox
D00341
D07CWD
DB01005
DivK1c_000556
DRG-0253
Droxia
Droxia (TM)
Droxia (TN)
DSSTox_CID_5438
DSSTox_GSID_25438
DSSTox_RID_77787
DTXSID6025438
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9
EBD12517
EINECS 204-821-7
EU-0100596
F8880-0905
FT-0083575
FT-0627160
GTPL6822
H 8627
H20210
Hidrix
Hidroxicarbamida
Hidroxicarbamida [INN-Spanish]
HMS1920F09
HMS2091L17
HMS2234I03
HMS3261H14
HMS3373G18
HMS3655K20
HMS501L18
HSDB 6887
HU
HY-B0313
Hydrea
Hydrea (Bristol Meyers)
Hydrea (TM)
HYDREA (TN)
Hydrea, Biosupressin, Cytodrox, Hydroxyurea
Hydreia
Hydroxicarbamidum
hydroxy urea
Hydroxy Urea-15N
HYDROXY-UREA
hydroxyaminomethanamide
Hydroxycarbamid
Hydroxycarbamide
hydroxycarbamide (hydroxyurea)
Hydroxycarbamide (JAN/INN)
Hydroxycarbamide [INN]
Hydroxycarbamide, European Pharmacopoeia (EP) Reference Standard
Hydroxycarbamidum
Hydroxycarbamidum [INN-Latin]
Hydroxycarbamine
Hydroxyharnstoff
Hydroxyharnstoff [German]
hydroxyl urea
Hydroxylamine, N-(aminocarbonyl)-
Hydroxylamine, N-carbamoyl-
Hydroxylurea
Hydroxyurea (Cytodrox)
Hydroxyurea (D4)
Hydroxyurea (USP)
Hydroxyurea [USAN:BAN]
Hydroxyurea [USAN:USP]
Hydroxyurea, 98%, powder
Hydroxyurea, United States Pharmacopeia (USP) Reference Standard
Hydroxyurea, Vetec(TM) reagent grade, >=98%
Hydroxyurea(d4)
Hydura
Hydurea
I05-0250
IDI1_000556
Idrossicarbamide
Idrossicarbamide [DCIT]
J-504798
KB-219051
KBio1_000556
KBio2_001389
KBio2_003957
KBio2_006525
KBio3_001384
KBioGR_000383
KBioSS_001389
KS-0000020X
KSC490O3R
Litaler
Litalir
Lopac-H-8627
Lopac0_000596
LP00596
LS-709
MCULE-9465284053
MFCD00007943
MLS001332381
MLS001332382
MLS002153389
MolMap_000029
MolPort-000-003-971
Mylocel
N-(Aminocarbonyl) Hydroxyamine
N-(Aminocarbonyl)hydroxylamine
N-Carbamoylhydroxylamine
N-HYDROXY UREA
N-Hydroxymocovina
N-Hydroxymocovina [Czech]
N-Hydroxyurea
NCGC00015520-01
NCGC00015520-02
NCGC00015520-03
NCGC00015520-04
NCGC00015520-05
NCGC00015520-06
NCGC00015520-07
NCGC00015520-08
NCGC00015520-09
NCGC00015520-10
NCGC00015520-11
NCGC00093974-01
NCGC00093974-02
NCGC00093974-03
NCGC00093974-04
NCGC00093974-05
NCGC00254007-01
NCGC00261281-01
NCI C04831
NCI-C04831
NCI60_002773
NCIMech_000139
NHY
NINDS_000556
NSC 32065
NSC-32065
NSC-757072
NSC32065
NSC757072
Onco-carbide
Oncocarbide
OR000156
OR211512
oxyrea
Oxyurea
Pharmakon1600-01500344
RP18352
RTR-003905
S-phase/G-1 interface inhibitor
s1896
SBI-0050578.P004
SC-17803
Siklos
SK 22591
SMR000059149
SPBio_000247
Spectrum_000909
SPECTRUM1500344
Spectrum2_000064
Spectrum3_000462
Spectrum4_000012
Spectrum5_000836
SQ 1089
SQ-1089
SR-01000075919
SR-01000075919-8
ST2415349
STL145898
tetratogen: inhibits ribonucleoside diphosphate reductase
TL8000673
Tox21_110168
Tox21_110168_1
Tox21_300319
Tox21_500596
TR-003905
TRA-0204880
UNII-X6Q56QN5QC
Urea, hydroxy-
urea, N-hydroxy-
VSNHCAURESNICA-UHFFFAOYSA-N
WLN: ZVMQ
X6Q56QN5QC
Z1522566612
ZINC100019199
ZINC8034120

US Patents and Regulatory Information for hydroxyurea

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb DROXIA hydroxyurea CAPSULE;ORAL 016295-003 Feb 25, 1998 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Addmedica Sas SIKLOS hydroxyurea TABLET;ORAL 208843-002 Dec 21, 2017 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr Labs Inc HYDROXYUREA hydroxyurea CAPSULE;ORAL 075020-001 Jul 30, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Addmedica Sas SIKLOS hydroxyurea TABLET;ORAL 208843-002 Dec 21, 2017 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Accenture
Argus Health
Healthtrust
Johnson and Johnson
AstraZeneca
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.